Factor V Leiden and prothrombin G20210A gene mutations in women with a history of thrombosis during pregnancy: Relation to pregnancy outcomes for mother and fetus

Saudi Medical Journal

Volumn 31, Issue 2, 2010, Pages 123-129

  Abu Skeen, Ibrahim A ^a   Mohamed, Amal A ^b   Moustafa, Nevine N ^c   Badawy, Mervat E ^d  

^a AL AZHAR UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d High Technological Institute   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA; PROTEIN C; PROTEIN S; PROTHROMBIN;

ABORTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS GROWTH; FETUS MONITORING; GENE MUTATION; GENOTYPE; HUMAN; INTRAUTERINE GROWTH RETARDATION; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; REAL TIME POLYMERASE CHAIN REACTION; SOLUTIO PLACENTAE; THROMBOEMBOLISM; THROMBOSIS;

BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FACTOR V; FEMALE; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN; THROMBOSIS;

EID: 77949518487     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Biron-Andreani C, Schved JF, Daures JP. Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis. Thromb Haemost 2006; 96: 14-18.
2. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002; 99: 333-341.
3. Lockwood CJ. Inherited thrombophilias in pregnant patients. Pregnant Neonat Med 2001; 6: 3-14.
4. Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 364-369.
5. Ancel PY, Marret S, Larroque B, Arnaud C, Zupan-Simunek V, Voyer M, et al. Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study. Am J Obstet Gynecol 2005; 193: 178-184.
6. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V leiden )R506Q( testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002; 126: 1304-1318.
7. Luderer R, Verheul A, Kortlandt W. Rapid detection of the factor V Leiden mutation by real-time PCR with TaqMan minor groove binder probes. Clin Chem 2004; 50: 787-788.
8. Berg CJ, Chang J, Callaghan WM, Whitehead SJ .Pregnancy related mortality in United States, 1991-1997. Abstract Gynecol 2003; 101: 289-296.
9. American College of Obstetricians and Gynecologists, Thromboembolism in pregnancy. ACOG practice bulletin no 19. Washington )DC(: ACG; 2000.
10. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-380.
11. González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, et al. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagul Fibrinolysis 2006; 17: 23-28.
12. Marchiori A, Mosena L, Prins MH, Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 2007; 92: 1107-1114.
13. Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, et al. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders. Br J Haematol 2002; 116: 625-631.
14. Bates SM, Ginsberg JS. How we manage venous thromboembolism during pregnancy. Blood 2002; 100: 3470-3478.
15. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106: 517-524.
16. Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V, et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998; 179: 1324-1328.
17. Tormene D, Simioni P, Prandoni P, Luni S, Zerbinati P, Sartor D, et al. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women. Haematologica 2001; 86: 1305-1309.
18. Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, et al. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 2001; 135: 322-327.
19. Mello G, Parretti E, Marozio L, Pizzi C, Lojacono A, Frusca T, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005; 46: 1270-1274.
20. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 2006; 99: 289-298.
21. De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S, et al. Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost 2004; 2: 1588-1593.
22. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000; 343: 1015-1018.
23. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 2000; 20: 266-270.
24. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361: 901-908.
25. Lissalde-Lavigne G, FabbroPeray P, Cochery-Nouvellon E, Mercier E, Riport Neveu S, Balducchi JR, et al. Factor V-leiden and prothrombin G 20210A polymorphism as risk factors for miscarriage during a first intended pregnancy. The matched case-control NOHA First study. Journal of Thrombosis and Haemostasis 2005; 3: 2178-2184.
26. Howley HE, Walker M, Rodger MA. systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694-708.